Enrichment and Purging of Stem Cells in the Treatment of Non-Hodgkin's Lymphoma

To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.



  • procedure : high dose chemo then auto hematopoietic cell transplant

Phase: N/A


Ages Eligible For Study:

N/A - 75 Years

Inclusion Criteria

- relapsed NHL

External Links

Explore related trials

Contact information

Primary Contact:

BMT Refferals 6507230822

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: